Speaker: Cristina Mussini
In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
For this episode, Cristina Mussini, Professor of Infectious Diseases at the University of Modena and Reggio Emilia in Italy, talks about interleukin inhibitors. She summarizes the current data on these agents, discusses why tocilizumab has given rise to clinical benefits in some studies but not others, and outlines what further work needs to be done (19:10).
Listen below or subscribe to this Podcast on:
About the speaker